Proton pump inhibitors associated with serious renal outcomes

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2016年 / 1599卷 / 1期
关键词：
D O I：
10.1007/s40278-016-16874-x
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：11 / 11
相关论文
共 50 条
  • [31] Proton pump inhibitors
    C. Scully
    British Dental Journal, 2010, 208 : 147 - 147
  • [32] PROTON PUMP INHIBITORS
    BARRY, A
    IRISH MEDICAL JOURNAL, 1994, 87 (05) : 134 - 134
  • [33] Proton pump inhibitors
    Naidoo, V
    SA PHARMACEUTICAL JOURNAL, 2016, 83 (01) : 9 - +
  • [34] Proton pump inhibitors
    Babb, Richard R.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (10) : 1296 - 1297
  • [35] Proton pump inhibitors
    Faure, Sebastien
    ACTUALITES PHARMACEUTIQUES, 2012, 51 (516): : 55 - 58
  • [36] Outcomes associated with proton pump inhibitors and distal radius fractures: A post-hoc comparative analysis
    Klifto, Kevin M.
    Ruch, David S.
    Mithani, Suhail K.
    Pidgeon, Tyler S.
    Richard, Marc J.
    Klifto, Christopher S.
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2022, 75 (08): : 2650 - 2657
  • [37] Using Proton Pump Inhibitors is not Associated With Adverse Outcomes in Patients With Chronic Myeloid Leukemia Treated With Dasatinib
    Haddad, Fadi G.
    Nasnas, Cedric
    Sasaki, Koji
    Paul, Shilpa
    Issa, Ghayas C.
    Rausch, Caitlin
    Jabbour, Elias
    Kantarjian, Hagop
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (07): : 484 - 487
  • [38] Proton pump inhibitors associated with all-cause mortality
    Reactions Weekly, 2017, 1660 (1) : 12 - 12
  • [39] Proton pump inhibitors are not associated with an increased risk of colorectal cancer
    Kuiper, Josephina G.
    Van Herk-Sukel, Myrthe P. P.
    Lemmens, Valery E. P. P.
    Kuipers, Ernst J.
    Herings, Ron M. C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 568 - 568
  • [40] Factors associated with the initiation of proton pump inhibitors in corticosteroid users
    Munson, Jeffrey C.
    Wahl, Peter M.
    Daniel, Gregory
    Kimmel, Stephen E.
    Hennessy, Sean
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (04) : 366 - 374
12345